
Humanigen, Inc.
USD0.00
-0.00 (-84.62%)
CEO
Cameron Durrant MBA
IPO Date
2013-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.24
Volume
2.06M
| 12 Jul 2022 |
| Cantor Fitzgerald |
| Overweight |
| Neutral |
| downgrade |
| 12 Jul 2022 | HC Wainwright & Co. | Buy | Neutral | downgrade |
| 12 Jul 2022 | Roth Capital | Buy | Neutral | downgrade |
| 10 Sept 2021 | Jefferies | Buy | Hold | downgrade |
| 9 Sept 2021 | HC Wainwright & Co. | Buy | Buy | maintain |
| 9 Sept 2021 | JP Morgan | Neutral | Underweight | downgrade |
| 9 Sept 2021 | Jefferies | Buy | Hold | downgrade |